Now showing items 1-1 of 1
Modeling variability for biologics strategic planning
(Massachusetts Institute of Technology, 2009)
Making strategic decisions about resource capabilities in the uncertain business of drug development is a challenging task. Novartis, a Swiss pharmaceutical company, is expanding from its success in small molecule therapeutics ...